Patents by Inventor Charles D. Nicholson

Charles D. Nicholson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of neuronal degeneration with 5HT1.sub.A agonists
    Patent number: 5162375
    Abstract: A method for the treatment and/or prophylaxis of disorders associated with neuronal degeneration resulting from ischaemic events, in mammals, such as humans, which comprises administering to the mammal in need of such treatment an effective amount of a 5-HT1.sub.A agonist.
    Type: Grant
    Filed: February 28, 1991
    Date of Patent: November 10, 1992
    Assignee: Beecham Group p.l.c.
    Inventors: Charles D. Nicholson, Johannes Jukna
  • Novel treatment for ischemia using an aminotetralin
    Patent number: 5049588
    Abstract: A method for the treatment and/or prophylaxis of disorders associated with neuronal degeneration resulting from ischaemic events, in mammals, such as humans, which comprises administering to the mammal in need of such treatment an effective amount of a 5-HTl.sub.A agonist.
    Type: Grant
    Filed: May 8, 1989
    Date of Patent: September 17, 1991
    Assignee: Beecham Group p.l.c.
    Inventors: Charles D. Nicholson, Johannes Jukna
  • Di/tetra-hydroquinolines
    Patent number: 4808619
    Abstract: Compounds of the formula ##STR1## as defined in the specification, and processes for their preparation and methods of using the compounds for the treatment of hypertension in mammals, such as humans and for the treatment and/or prophylaxis of cerebrovascular disorders and/or disorders associated with cerebral senility in mammals, such as humans.
    Type: Grant
    Filed: July 30, 1986
    Date of Patent: February 28, 1989
    Assignee: Beecham Group p.l.c.
    Inventors: John M. Evans, Geoffrey Stemp, Charles D. Nicholson, Dieter Angersbach
  • Novel treatment
    Patent number: 4784999
    Abstract: A method for the treatment of cerebral vascular and neuronal degenerative disorders associated with learning, memory and cognitive dysfunctions including cerebral senility, multi-infarct dementia and senile dementia of the Alzheimer type and/or peripheral vascular disease and/or proliferative skin disease in mammals, such as humans, which comprises administering to the mammal in need of such treatment an effective amount of 1,3-di-n-butyl-7-(2-oxypropyl) xanthine or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 11, 1987
    Date of Patent: November 15, 1988
    Assignee: Beecham Wuelfing GmbH & Co. KG
    Inventors: Dieter Angersbach, Charles D. Nicholson, Joachim Goring, Brian Morgan, Jonathan R. S. Arch